Abstract
Overview of Clinical Intelligence Report Series
Austin Research Analytics Group' s (ARAG) Clinical Intelligence Report Series
provides clients within the pharmaceutical and biotechnology industry with
detailed competitive information to facilitate key analysis and
decision-making. Clients utilize the report as an resource to support key
decisions including:
- Analyzing the overall depth and breadth of the competitive landscape
within a therapeutic area
- Assessing target product profiles of key current and future competitors
- Benchmarking competitor clinical trial designs and results
- Developing clinical analogues to support go-no-go decisions
- Identifying clinical hurdles posed by competitors
- Designing clinical trials more effectively to maximize a product' s
penetration
Reports contain synthesized information and analysis of clinical development
activities for key marketed and pipeline products within multiple therapeutic
categories and generally include the following data points:
- Product Overview: Mechanism of Action, Developing Companies, Indications
and Phase of Development.
- Clinical Trial Assessments: Detailed evaluations of completed and ongoing
competitor studies that capture key elements of the study protocol including:
- Trial design
- Start and end dates
- Study size and patient type
- Number of participating sites
- Dosing regimen
- Endpoints
- Safety and efficacy results
View Cart
